In Vivo Emergence of Ceftazidime/Avibactam, Cefiderocol and Aztreonam/Avibactam Cross-Resistance in a Patient With KPC-Producing Klebsiella pneumoniae Infection After Cefiderocol-Based Treatment

被引：2
|
作者：
Bianco, Gabriele [1 ]
Boattini, Matteo [2 ,3 ]
Comini, Sara [2 ,4 ]
Gibellini, Davide [5 ]
Gaibani, Paolo [5 ]
机构：
[1] Univ Salento, Dept Expt Med, Lecce, Italy
[2] Univ Torino, Dept Publ Hlth & Paediat, Turin, Italy
[3] Lisbon Acad Med Ctr, Lisbon, Portugal
[4] Carlo Urbani Hosp, Operat Unit Clin Pathol, Jesi, Ancona, Italy
[5] Univ Verona, Dept Diagnost & Publ Hlth, Microbiol Sect, Verona, Italy
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2024年 / 64卷 / 05期
关键词：
D O I：
10.1016/j.ijantimicag.2024.107343
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam-based therapies
    Amadesi, Stefano
    Amedeo, Alberto
    Rinaldi, Matteo
    Palombo, Marta
    Giannella, Maddalena
    Gaibani, Paolo
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2024, 110 (01)
  • [2] The Effect of β-Lactam Antibiotics on the Evolution of Ceftazidime/Avibactam and Cefiderocol Resistance in KPC-Producing Klebsiella pneumoniae
    Zhang, Ping
    Hu, Huangdu
    Shi, Qiucheng
    Sun, Long
    Wu, Xueqing
    Hua, Xiaoting
    McNally, Alan
    Jiang, Yan
    Yu, Yunsong
    Du, Xiaoxing
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (03)
  • [3] Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment
    Amadesi, Stefano
    Gatti, Milo
    Rinaldi, Matteo
    Pea, Federico
    Viale, Pierluigi
    Gaibani, Paolo
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (04)
  • [4] High-level cefiderocol and ceftazidime/avibactam resistance in KPC-producing Klebsiella pneumoniae associated with mutations in KPC and the sensor histidine kinase EnvZ
    Findlay, Jacqueline
    Bianco, Gabriele
    Boattini, Matteo
    Nordmann, Patrice
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2025,
  • [5] Avibactam/ceftazidime/meropenemDevelopment of resistance in KPC-producing Klebsiella pneumoniae infection: case report
    Reactions Weekly, 2018, 1709 (1) : 42 - 42
  • [6] Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo
    Goettig, Stephan
    Frank, Denia
    Mungo, Eleonora
    Nolte, Anika
    Hogardt, Michael
    Besier, Silke
    Wichelhaus, Thomas A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (11) : 3211 - 3216
  • [7] In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae
    Huang, Yanqin
    Wu, Tiffany
    Perez, Omar
    Rana, Amisha P.
    Chen, Liang
    Kreiswirth, Barry N.
    Satlin, Michael J.
    Bulman, Zackery P.
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [8] In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing Enterobacterales: cross-resistance and synergistic effects
    Gabriele Bianco
    Matteo Boattini
    Sara Comini
    Marco Iannaccone
    Alessandro Bondi
    Rossana Cavallo
    Cristina Costa
    European Journal of Clinical Microbiology & Infectious Diseases, 2022, 41 : 63 - 70
  • [9] In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing Enterobacterales: cross-resistance and synergistic effects
    Bianco, Gabriele
    Boattini, Matteo
    Comini, Sara
    Iannaccone, Marco
    Bondi, Alessandro
    Cavallo, Rossana
    Costa, Cristina
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2022, 41 (01) : 63 - 70
  • [10] Cross-resistance to cefiderocol and ceftazidime-avibactam in KPC β-lactamase mutants and the inoculum effect
    Hobson, Claire Amaris
    Cointe, Aurelie
    Jacquier, Herve
    Choudhury, Alaksh
    Magnan, Melanie
    Courroux, Celine
    Tenaillon, Olivier
    Bonacorsi, Stephane
    Birgy, Andre
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (08) : 1172.e7 - 1172.e10
12345